Coronavirus Update: At One-Year Mark, WHO Stresses Importance Of Fair Vaccine Distribution
Pfizer CEO Reflects On Pandemic Anniversary
Plus Pfizer/BioNTech report real-world data from Israel on its vaccine, while Roche’s Actemra misses Phase III endpoint in another combo study with Veklury.
You may also be interested in...
Coronavirus Update: Pfizer/BioNTech Vaccine Shows Six-Month, Variant Protection
The companies still plan to develop a variant-specific version, while J&J said it anticipates meeting vaccine supply goals despite a manufacturing mix-up.
Humanigen Data Show Success In High-Risk COVID-19 Population
Phase III results show benefit in cytokine-release syndrome, while other drugs for treating patients hospitalized with COVID-19 have produced mixed results.
Coronavirus Update: How Vaccines Stack Up Against Variants So Far
Plus: Sanofi is getting into the mRNA vaccine game under a partnership with Translate Bio but has a lot of catching up to do.